NORWALK, Conn.--Perkin-Elmer's third-quarter results announcement last month pointed to positive developments at its Celera Genomics group. By the end of April, Celera had 300 employees and laboratories and related facilities were almost fully built. The company's staff has begun sequencing the Drosophila melanogaster genome and the unit is cooperating with Compaq Computer to build one of the world's largest supercomputing centers. Amgen, Pharmacia & Upjohn, and Novartis Pharma have all signed five-year subscription agreements to Celera databases.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.